Secreted Non-Coding RNAs: Functional Impact on the Tumor Microenvironment and Clinical Relevance in Triple-Negative
Silvia Di Agostino1, Mahrou Vahabi2, Chiara Turco2
1Department of Health Sciences, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy.
Abstract:
Triple-negative breast cancer (TNBC) is a subtype of breast carcinoma characterized by poor prognosis and high rate of metastasis. Current treatment is based on chemo- and/or radiotherapy and surgery. TNBC is devoid of estrogen, progesterone and HER2 receptors. Although precision medicine has come a long way to ameliorate breast cancer disease management, targeted therapies for the treatment of TNBC patients are still limited. Mounting evidence has shown that non-coding RNAs (ncRNAs) drive many oncogenic processes at the basis of increased proliferation, invasion and angiogenesis in TNBC, strongly contributing to tumor progression and resistance to treatments. Many of these ncRNAs are secreted in the tumor microenvironment (TME) and impinge on the activity of the diverse immune and stromal cell types infiltrating the TME. Importantly, secreted ncRNAs may be detected as circulating molecules in serum/plasma from cancer patients and are emerging a promising diagnostic/therapeutic tools in TNBC. This review aims to discuss novel insights about the role of secreted circulating ncRNAs in the intercellular communication in the tumor microenvironment and their potential clinical use as diagnostic and prognostic non-invasive biomarkers in TNBC.
Insights
Secreted non-coding RNAs (ncRNAs) play a crucial role in triple-negative breast cancer (TNBC) progression and treatment resistance. These molecules, found in circulation, show promise as non-invasive diagnostic and prognostic biomarkers for TNBC.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Triple-negative breast cancer (TNBC) presents a poor prognosis and high metastatic potential due to a lack of targeted therapies.
- Current TNBC treatments rely on chemotherapy, radiotherapy, and surgery, with limited success in precision medicine.
- Non-coding RNAs (ncRNAs) are increasingly recognized for their role in TNBC's oncogenic processes, including proliferation, invasion, and angiogenesis.
Purpose of the Study:
- To review the role of secreted circulating ncRNAs in intercellular communication within the tumor microenvironment (TME) of TNBC.
- To explore the potential of these ncRNAs as diagnostic and prognostic non-invasive biomarkers for TNBC patients.
- To highlight novel insights into how ncRNAs contribute to TNBC progression and treatment resistance.
Main Methods:
- Literature review focusing on the function and detection of secreted ncRNAs in TNBC.
- Analysis of studies investigating the impact of ncRNAs on tumor microenvironment components.
- Examination of research on the diagnostic and prognostic value of circulating ncRNAs in TNBC.
Main Results:
- Secreted ncRNAs are implicated in driving proliferation, invasion, and angiogenesis in TNBC.
- These ncRNAs modulate immune and stromal cell activity within the TME.
- Circulating ncRNAs in serum/plasma are emerging as promising biomarkers for TNBC detection and prognosis.
Conclusions:
- Secreted circulating ncRNAs are key mediators of intercellular communication in the TNBC TME.
- These molecules represent a significant advancement in the development of non-invasive diagnostic and prognostic tools for TNBC.
- Targeting or utilizing these ncRNAs may offer novel therapeutic strategies for TNBC management.
Related Concept Videos
MicroRNAs
lncRNA - Long Non-coding RNAs
The Tumor Microenvironment
The Nucleolus
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...


